Divi’s Laboratories Ltd.: What makes the latest pharma company to enter Nifty very different from its peers in the index?


ET Intelligence Group: An 80% gain in the stock of Divi’s Labs during the past five months has catapulted the company into the Nifty-50 Index. The Hyderabad-based pharma company, however, is quite different from peers Sun Pharma, Cipla and Dr Reddy’s Labs, and predecessors Lupin and Aurobindo Pharma in the index. It is the smallest pharma company by revenues among all of them, but is trading at one of the highest valuations due to its superior





Source link

Share This Post

Share on whatsapp
Share on facebook
Share on twitter
Share on pinterest
Share on reddit
Share on telegram
Share on email
Share on linkedin
Share on print

Posted By :

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More to Explore

Want to Write Such Blogs?

Just Fill in Your Details to get started

Want to Write such blogs?

Join in like all our authors and be a part of this community

small_c_popup.png

Hello

We are happy you are here

[wppb-login]

Oh No!

It seems like you have forgotten your password. Don’t worry tell us your email id or username and we’ll try to help
Share on whatsapp
Share on twitter
Share on facebook
Share on pinterest
Share on reddit
Share on telegram
Share on email
Share on linkedin
Share on print
error: Alert: Content is protected !!
Secured By miniOrange